AU409 PRESENTED at AACR

At AACR 2026, Anthony El-khoueiry, MD, of USC Norris Comprehensive Cancer Center, presented a late-breaking poster on AU409, a first-in-class transcription regulator being evaluated in hepatocellular carcinoma and other advanced solid tumors, to Harpreet Singh, MD, of Precision for Medicine.

Following our late-breaking poster presentation at #AACR2026, Harpreet Singh, MD, of Precision for Medicine spoke with Pek Lum, PhD, CEO of Auransa, about AU409 and its ongoing clinical development in hepatocellular carcinoma and other advanced solid tumors, as well as Auransa’s Biology-first drug discovery platform.